In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.
1996 ◽
Vol 40
(10)
◽
pp. 2416-2419
◽
Keyword(s):
The in vitro activities of LY333328 were compared with those of vancomycin, teicoplanin, and quinupristin-dalfopristin (Synercid) against 219 strains of enterococci and staphylococci, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. MICs and MBCs were determined by a microtiter dilution protocol. LY333328 demonstrated superior activity against vancomycin-resistant enterococci and was the only antibiotic which was bactericidal. Its potency was comparable or superior to those of other antibiotics tested against methicillin-resistant staphylococci.
2007 ◽
Vol 29
(2)
◽
pp. 191-196
◽
1999 ◽
Vol 34
(2)
◽
pp. 119-122
◽
1998 ◽
Vol 30
(2)
◽
pp. 89-92
◽
2000 ◽
Vol 38
(3)
◽
pp. 177-179
◽
1993 ◽
Vol 17
(4)
◽
pp. 265-270
◽
2009 ◽
Vol 4
(10)
◽
pp. 366-369
◽
2005 ◽
Vol 49
(9)
◽
pp. 3933-3936
◽